Apremilast-d5

Modify Date: 2024-01-02 04:02:20

Apremilast-d5 Structure
Apremilast-d5 structure
Common Name Apremilast-d5
CAS Number 1258597-47-5 Molecular Weight 465.53100
Density N/A Boiling Point N/A
Molecular Formula C22H19D5N2O7S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Apremilast-d5


Apremilast D5 (CC-10004 D5) is a deuterium labeled Apremilast. Apremilast is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM[1].

 Names

Name (S)-N-(2-(2-(methylsulfonyl)-1-(3-(ethoxy-d5)-4-(methoxy)phenyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide
Synonym More Synonyms

 Apremilast-d5 Biological Activity

Description Apremilast D5 (CC-10004 D5) is a deuterium labeled Apremilast. Apremilast is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM[1].
Related Catalog
Target

PDE4

TNF-α

References

[1]. Perez-Aso M, et al. Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors. Arthritis Res Ther. 2015 Sep 15;17:249.

 Chemical & Physical Properties

Molecular Formula C22H19D5N2O7S
Molecular Weight 465.53100
Exact Mass 465.16200
PSA 127.46000
LogP 3.52590

 Synonyms

Apremilast D5
Apremilast-d5